![Christopher Meldrum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Meldrum
Director Ejecutivo en
Avicenna Biosciences, Inc.
.
Perfil
Christopher S.
Meldrum was the founder of Exigent Pharmaceuticals, Inc., founded in 2007, where the title held was Acting President.
The current job is President, Chief Executive Officer & Director at Avicenna Biosciences, Inc. Former jobs include President, Chief Executive Officer & Director at Pique Therapeutics, Inc.; President & Chief Executive Officer at Arcato Laboratories, Inc.; Chairman at Kylin Therapeutics, Inc.; Director at Cogenics Icoria, Inc.; Managing Director at Golden Pine Ventures LLC from 2004 to 2019; Secretary & Director at Catena Pharmaceuticals, Inc. from 2012 to 2013; and Principal at Purdue University and the University of Minnesota.
Education includes an undergraduate degree from the University of Utah and an MBA from the University of Minnesota.
Cargos activos de Christopher Meldrum
| Empresas | Cargo | Inicio |
|---|---|---|
Avicenna Biosciences, Inc.
 Avicenna Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that intends to redesign and optimize drug candidates | Director Ejecutivo | - |
Antiguos cargos conocidos de Christopher Meldrum.
| Empresas | Cargo | Fin |
|---|---|---|
Golden Pine Ventures LLC
 Golden Pine Ventures LLC Investment ManagersFinance Golden Pine Ventures LLC invests in companies located in the US. They target companies operating in the fields of biotechnology and biomedical opportunities which have the potential to yield a substantial return within a 3 to 5-year period. They provide financing for seed and early stage capital requirements. The firm seeks an equal equity ownership position in these new companies. | Inversor de Capital Privado | 01/07/2019 |
Catena Pharmaceuticals, Inc.
 Catena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer drugs | Director/Miembro de la Junta | 09/07/2013 |
Kylin Therapeutics, Inc.
 Kylin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Presidente | 01/07/2013 |
Arcato Laboratories, Inc.
 Arcato Laboratories, Inc. Medical SpecialtiesHealth Technology Develops, produces and commercializes oral healthcare products | Director Ejecutivo | - |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formación de Christopher Meldrum.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
4
Relaciones de 1er grado
11
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
Cogenics Icoria, Inc.
 Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Kylin Therapeutics, Inc.
Kylin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Golden Pine Ventures LLC
Golden Pine Ventures LLC Investment ManagersFinance Golden Pine Ventures LLC invests in companies located in the US. They target companies operating in the fields of biotechnology and biomedical opportunities which have the potential to yield a substantial return within a 3 to 5-year period. They provide financing for seed and early stage capital requirements. The firm seeks an equal equity ownership position in these new companies. | Finance |
Catena Pharmaceuticals, Inc.
Catena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer drugs | Health Technology |
Exigent Pharmaceuticals, Inc.
 Exigent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Pique Therapeutics, Inc.
 Pique Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic vaccines for the treatment of cancer | Health Technology |
Arcato Laboratories, Inc.
Arcato Laboratories, Inc. Medical SpecialtiesHealth Technology Develops, produces and commercializes oral healthcare products | Health Technology |
Avicenna Biosciences, Inc.
Avicenna Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that intends to redesign and optimize drug candidates | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Meldrum
